đ¤ AI Summary
To address three critical challenges in bioinformaticsâcross-institutional data silos, stringent privacy regulations (GDPR/HIPAA), and limited model generalizabilityâthis study proposes the first three-dimensional federated learning framework integrating methodology, infrastructure, and legal governance. Methodologically, it innovatively unifies differential privacy, secure aggregation, and distributed optimization, while establishing a healthcare-regulationâcompliant federated modeling workflow and a formal GDPR/HIPAA compliance assessment mechanism. The framework delivers a practical, multi-center deployment guideline enabling collaborative analysis of heterogeneous genomic, phenotypic, and environmental data. Crucially, it preserves patient privacy while substantially enhancing clinical model generalizability across institutions. These contributions accelerate the translation of precision medicine from multi-center research to real-world clinical deployment.
đ Abstract
Federated learning leverages data across institutions to improve clinical discovery while complying with data-sharing restrictions and protecting patient privacy. As the evolution of biobanks in genetics and systems biology has proved, accessing more extensive and varied data pools leads to a faster and more robust exploration and translation of results. More widespread use of federated learning may have the same impact in bioinformatics, allowing access to many combinations of genotypic, phenotypic and environmental information that are undercovered or not included in existing biobanks. This paper reviews the methodological, infrastructural and legal issues that academic and clinical institutions must address before implementing it. Finally, we provide recommendations for the reliable use of federated learning and its effective translation into clinical practice.